Package 0008-1210-30

{"route": ["ORAL"], "spl_id": "1bdeb7f1-3871-48b2-9fa9-7fdb714faf3f", "openfda": {"upc": ["0300081210306", "0300081222309", "0300081211303"], "unii": ["ZB22ENF0XR"], "rxcui": ["790267", "790290", "1607617", "1607619", "1874553", "1874559"], "spl_set_id": ["0f43610c-f290-46ea-d186-4f998ed99fce"], "manufacturer_name": ["Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1210-30)", "package_ndc": "0008-1210-30", "marketing_start_date": "20150401"}], "brand_name": "Pristiq Extended-Release", "product_id": "0008-1210_1bdeb7f1-3871-48b2-9fa9-7fdb714faf3f", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "0008-1210", "generic_name": "desvenlafaxine succinate", "labeler_name": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pristiq", "brand_name_suffix": "Extended-Release", "active_ingredients": [{"name": "DESVENLAFAXINE SUCCINATE", "strength": "25 mg/1"}], "application_number": "NDA021992", "marketing_category": "NDA", "marketing_start_date": "20150401", "listing_expiration_date": "20261231"}